Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

This Phase III study (EXPAND) is testing whether targeted local treatments — such as radiation, surgery, or ablation — to all visible tumor sites can improve survival in patients with pancreatic cancer that has spread to just a few places (called oligometastatic disease). **You may be eligible if...** - You are 18 or older - You have been diagnosed with pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer) - You have between 1 and 5 distant tumor sites that can all be treated with local therapy - Your general health status allows for active treatment (ECOG score 0-2) - All of your tumor sites, including any spread, can be targeted with radiation, surgery, or ablation **You may NOT be eligible if...** - You have more than 5 separate metastatic spots - Any of your tumors cannot be safely treated with local therapy - Your general health is too poor to tolerate treatment Talk to your doctor to see if this trial is right for you.